An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets

NCT00643851 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

994

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Dapagliflozin
DRUG: Metformin XR

Sponsor

AstraZeneca

Collaborators

[object Object]